Education
About Us
Working with TipRanks
Follow Us
Azenta (AZTA)
NASDAQ:AZTA
AZTA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.36 - $63.58
Previous CloseN/A
Volume88.55K
Average Volume (3M)838.27K
Market Cap
$1.26B
Enterprise Value$1.87B
Total Cash (Recent Filing)$48.62M
Total Debt (Recent Filing)$11.10M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
May 12, 2025EPS Estimate
0.08Last Dividend Ex-Date
Dec 02, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-2.99
Shares Outstanding45,695,590
10 Day Avg. Volume1,027,499
30 Day Avg. Volume838,267
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.63
Price to Cash Flow (P/CF)14.00
P/FCF Ratio19.40
Enterprise Value/Market Cap1.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.10
Enterprise Value/Ebitda116.35
Forecast
1Y Price Target
$53.67Price Target Upside107.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Azenta News
PremiumCompany Announcements
Azenta Announces Departure of Key Executive David Wang
PremiumCompany Announcements
Azenta, Inc. Shows Positive Outlook in Earnings Call
PremiumCompany Announcements
Azenta, Inc. Reports Strong Q1 2025 Results
---
Bulls Say, Bears Say
Bulls Say
Divestiture PlansThe planned divestiture of the underperforming B Medical segment is expected to be a key catalyst for improving the stock's performance.
Management And Operational EffortsThere is plenty of room for margin expansion at Azenta, especially on the operational expense side.
Strategic RestructuringThe new management team has initiated a strategic restructuring to focus on higher margin segments, which is seen as a necessary move for future growth.
Bears Say
Geopolitical And Segment ChallengesThe company is facing significant geopolitical tensions and challenges in the vaccine cold chain segment, which have been major obstacles in recent months.
Market UncertaintiesUncertainties around NIH funding and trade tensions with China are significant concerns for investors due to Azenta's exposure in the multiomics segment.
---
Ownership Overview
11.35% Insiders
30.10% Mutual Funds
0.12% Other Institutional Investors
27.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AZTA FAQ
What was Azenta’s price range in the past 12 months?
Azenta lowest stock price was $25.36 and its highest was $63.58 in the past 12 months.
What is Azenta’s market cap?
Azenta’s market cap is $1.26B.
When is Azenta’s upcoming earnings report date?
Azenta’s upcoming earnings report date is May 12, 2025 which is in 26 days.
How were Azenta’s earnings last quarter?
Azenta released its earnings results on Feb 05, 2025. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.057 by $0.023.
Is Azenta overvalued?
According to Wall Street analysts Azenta’s price is currently Undervalued.
Does Azenta pay dividends?
Azenta pays a Quarterly dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Azenta dividends here
What is Azenta’s EPS estimate?
Azenta’s EPS estimate is 0.08.
How many shares outstanding does Azenta have?
Azenta has 45,695,590 shares outstanding.
What happened to Azenta’s price movement after its last earnings report?
Azenta reported an EPS of $0.08 in its last earnings report, beating expectations of $0.057. Following the earnings report the stock price went up 3.444%.
Which hedge fund is a major shareholder of Azenta?
Currently, no hedge funds are holding shares in AZTA
---
Azenta Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.67 (107.14% Upside)
$53.67 (107.14% Upside)
Hedge Fund Trend
Increased
By 248.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $16.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 7.1%
Last 30 Days ▼ 23.2%
Last 30 Days ▼ 23.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.61%
12-Months-Change
Fundamentals
Return on Equity
-7.58%
Trailing 12-Months
Asset Growth
-27.73%
Trailing 12-Months
Company Description
Azenta
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
---
AZTA Company Deck
---
AZTA Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a cautiously optimistic outlook for fiscal year 2025, with several positive developments in the company's operations and financial health. Despite a few challenges, such as declining Sanger Sequencing revenue and uncertainties in large stores revenue, the company maintains a strong cash position and has shown significant operational improvements. The overall sentiment of the call is positive, given the strong financial performance and strategic initiatives underway.Read More>---
AZTA Stock 12 Month Forecast
Average Price Target
$53.67
▲(107.14% Upside)
Technical Analysis
Best Analysts Covering AZTA
1 Year
1 Year Success Rate
3/24 ratings generated profit
1 Year Average Return
-26.00%
reiterated a buy rating 2 months ago
Copying David Saxon's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -26.00% per trade.
---